Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 524

1.

Assessing cancer risk factors faced by an Ancestral Puebloan population in the North American Southwest.

Whitley CB, Boyer JL.

Int J Paleopathol. 2018 Jun;21:166-177. doi: 10.1016/j.ijpp.2017.06.004. Epub 2017 Aug 23.

PMID:
29778412
2.

OSTα-OSTβ Guards the Ileal Enterocyte From the Accumulation of Toxic Levels of Bile Acids.

Boyer JL.

Cell Mol Gastroenterol Hepatol. 2018 Feb 10;5(4):649-650. doi: 10.1016/j.jcmgh.2018.01.015. eCollection 2018. No abstract available.

3.

Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents.

Yu D, Cai SY, Mennone A, Vig P, Boyer JL.

Liver Int. 2018 Jun;38(6):1128-1138. doi: 10.1111/liv.13698. Epub 2018 Feb 13.

4.

Primary Sclerosing Cholangitis Is Not Rare Among Blacks in a Multicenter North American Consortium.

Goldberg DS, Levy C, Yimam K, Gordon SC, Forman L, Verna E, Yu L, Rahimi R, Schwarz K, Eksteen B, Pratt D, Boyer JL, Assis D, Bowlus C.

Clin Gastroenterol Hepatol. 2018 Apr;16(4):591-593. doi: 10.1016/j.cgh.2017.10.028. Epub 2017 Nov 2. No abstract available.

PMID:
29102704
5.

Maintaining a Vibrant and Productive Laboratory as a Senior Investigator.

Boyer JL.

Cell Mol Gastroenterol Hepatol. 2017 Jun 7;4(2):299-300. doi: 10.1016/j.jcmgh.2017.04.008. eCollection 2017 Sep. No abstract available.

6.

Studies on the mechanisms of bile acid initiated hepatic inflammation in cholestatic liver injury.

Cai SY, Boyer JL.

Inflamm Cell Signal. 2017;4(2). pii: e1561. Epub 2017 Jun 19.

7.

Mechanisms of bile acid mediated inflammation in the liver.

Li M, Cai SY, Boyer JL.

Mol Aspects Med. 2017 Aug;56:45-53. doi: 10.1016/j.mam.2017.06.001. Epub 2017 Jul 1. Review.

PMID:
28606651
8.

Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response.

Cai SY, Ouyang X, Chen Y, Soroka CJ, Wang J, Mennone A, Wang Y, Mehal WZ, Jain D, Boyer JL.

JCI Insight. 2017 Mar 9;2(5):e90780. doi: 10.1172/jci.insight.90780.

9.

The Role of Inflammation in the Mechanisms of Bile Acid-Induced Liver Damage.

Cai SY, Boyer JL.

Dig Dis. 2017;35(3):232-234. doi: 10.1159/000450916. Epub 2017 Mar 1.

PMID:
28249287
10.

Na+-taurocholate cotransporting polypeptide (NTCP/SLC10A1) ortholog in the marine skate Leucoraja erinacea is not a physiological bile salt transporter.

Yu D, Zhang H, Lionarons DA, Boyer JL, Cai SY.

Am J Physiol Regul Integr Comp Physiol. 2017 Apr 1;312(4):R477-R484. doi: 10.1152/ajpregu.00302.2016. Epub 2017 Jan 11.

11.

CFTR-associated ligand is a negative regulator of Mrp2 expression.

Li M, Soroka CJ, Harry K, Boyer JL.

Am J Physiol Cell Physiol. 2017 Jan 1;312(1):C40-C46. doi: 10.1152/ajpcell.00100.2016. Epub 2016 Nov 9.

12.

Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis.

Kulkarni SR, Soroka CJ, Hagey LR, Boyer JL.

Hepatology. 2016 Dec;64(6):2151-2164. doi: 10.1002/hep.28826. Epub 2016 Oct 28.

13.

A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients.

Assis DN, Takahashi H, Leng L, Zeniya M, Boyer JL, Bucala R.

Dig Dis Sci. 2016 Dec;61(12):3506-3512. Epub 2016 Oct 1.

14.

Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot Study.

Assis DN, Abdelghany O, Cai SY, Gossard AA, Eaton JE, Keach JC, Deng Y, Setchell KD, Ciarleglio M, Lindor KD, Boyer JL.

J Clin Gastroenterol. 2017 Feb;51(2):e11-e16. doi: 10.1097/MCG.0000000000000591.

15.

A Novel Di-Leucine Motif at the N-Terminus of Human Organic Solute Transporter Beta Is Essential for Protein Association and Membrane Localization.

Xu S, Soroka CJ, Sun AQ, Backos DS, Mennone A, Suchy FJ, Boyer JL.

PLoS One. 2016 Jun 28;11(6):e0158269. doi: 10.1371/journal.pone.0158269. eCollection 2016.

16.

Canalicular membrane MRP2/ABCC2 internalization is determined by Ezrin Thr567 phosphorylation in human obstructive cholestasis.

Chai J, Cai SY, Liu X, Lian W, Chen S, Zhang L, Feng X, Cheng Y, He X, He Y, Chen L, Wang R, Wang H, Boyer JL, Chen W.

J Hepatol. 2015 Dec;63(6):1440-8. doi: 10.1016/j.jhep.2015.07.016. Epub 2015 Jul 23.

17.

Na(+) /H(+) exchanger regulatory factor 1 knockout mice have an attenuated hepatic inflammatory response and are protected from cholestatic liver injury.

Li M, Mennone A, Soroka CJ, Hagey LR, Ouyang X, Weinman EJ, Boyer JL.

Hepatology. 2015 Oct;62(4):1227-36. doi: 10.1002/hep.27956. Epub 2015 Aug 22.

18.

A Novel Small-Molecule Inhibitor Targeting CREB-CBP Complex Possesses Anti-Cancer Effects along with Cell Cycle Regulation, Autophagy Suppression and Endoplasmic Reticulum Stress.

Lee JW, Park HS, Park SA, Ryu SH, Meng W, Jürgensmeier JM, Kurie JM, Hong WK, Boyer JL, Herbst RS, Koo JS.

PLoS One. 2015 Apr 21;10(4):e0122628. doi: 10.1371/journal.pone.0122628. eCollection 2015.

19.

Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats.

Perry RJ, Zhang D, Zhang XM, Boyer JL, Shulman GI.

Science. 2015 Mar 13;347(6227):1253-6. doi: 10.1126/science.aaa0672. Epub 2015 Feb 26.

20.

Fibrates and cholestasis.

Ghonem NS, Assis DN, Boyer JL.

Hepatology. 2015 Aug;62(2):635-43. doi: 10.1002/hep.27744. Epub 2015 Mar 23. Review.

Supplemental Content

Loading ...
Support Center